Extracellular matrix in cardiovascular pathophysiology: Proteomics reveals rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice

Sarah J. Parker, Aleksandr Stotland, Elena Macfarlane, Nicole Wilson, Amanda Orosco, Vidya Venkatraman, Kyle Madrid, Roberta Gottlieb, Harry C. Dietz, Jennifer E. Van Eyk

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The objective of the present study was to 1) analyze the ascending aortic proteome within a mouse model of Marfan syndrome (MFS; Fbn1C1041G/+) at early and late stages of aneurysm and 2) subsequently test a novel hypothesis formulated on the basis of this unbiased proteomic screen that links changes in integrin composition to transforming growth factor (TGF)-β-dependent activation of the rapamycin-independent component of mammalian target of rapamycin (Rictor) signaling pathway. Ingenuity Pathway Analysis of over 1,000 proteins quantified from the in vivo MFS mouse aorta by data-independent acquisition mass spectrometry revealed a predicted upstream regulator, Rictor, that was selectively activated in aged MFS mice. We validated this pattern of Rictor activation in vivo by Western blot analysis for phosphorylation on Thr1135 in a separate cohort of mice and showed in vitro that TGF-β activates Rictor in an integrin-linked kinase-dependent manner in cultured aortic vascular smooth muscle cells. Expression of β3-integrin was upregulated in the aged MFS aorta relative to young MFS mice and wild-type mice. We showed that β3-integrin expression and activation modulated TGF-β-induced Rictor phosphorylation in vitro, and this signaling effect was associated with an altered vascular smooth muscle cell proliferative-migratory and metabolic in vitro phenotype that parallels the in vivo aneurysm phenotype in MFS. These results reveal that Rictor is a novel, context-dependent, noncanonical TGF-β signaling effector with potential pathogenic implications in aortic aneurysm. NEW & NOTEWORTHY We present the most comprehensive quantitative analysis of the ascending aortic aneurysm proteome in Marfan syndrome to date resulting in novel and potentially wide-reaching findings that expression and signaling by β3-integrin constitute a modulator of transforming growth factor-β-induced rapamycin-independent component of mammalian target of rapamycin (Rictor) signaling and physiology in aortic vascular smooth muscle cells.

Original languageEnglish (US)
Pages (from-to)H1112-H1126
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume315
Issue number5
DOIs
StatePublished - Oct 2018

Keywords

  • Aortic aneurysm
  • Data-independent acquisition mass spectrometry
  • Integrin signaling
  • Marfan syndrome
  • Rictor
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Extracellular matrix in cardiovascular pathophysiology: Proteomics reveals rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice'. Together they form a unique fingerprint.

Cite this